Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122724471> ?p ?o ?g. }
- W2122724471 endingPage "672" @default.
- W2122724471 startingPage "663" @default.
- W2122724471 abstract "Background Intraductal papillary mucinous neoplasms (IPMN) represent a spectrum of tumors that range from low-grade (LG) dysplastic tumors to invasive cancer. Identification of IPMN at high risk for malignant transformation is important for the prevention and early treatment of pancreatic cancer. The roles of microRNA expression in the development of IPMN have not been extensively evaluated. Methods Expression patterns of 846 human microRNAs (miRNAs) was analyzed using microRNA microarray in 55 tissues, including LG IPMN (n = 10), moderate-grade (MG) IPMN (n = 5), high-grade (HG) IPMN (n = 5), invasive cancer with IPMN (IPMC; n = 10), pancreatic ductal adenocarcinoma without IPMN (PDA; n = 5), LG IPMN extracted from specimens that contain IPMC (LG_Ca; n = 10), and normal pancreatic tissues (n = 10). Results Fourteen miRNAs were differentially expressed in all IPMN tissues compared with normal pancreatic tissue. Expression level of 3 miRNAs was proportional to dysplasia level. Hierarchical clustering demonstrated grouping of 2 IPMN subgroups: LG and MG IPMN verses HG IPMN and IPMC. Expression of 15 miRNAs was significantly different between these groups. LG_Ca tissues clustered with the HG IPMC group, and 12 miRNAs were differentially expressed in LG_Ca, HG lesions, and IPMC compared with LG lesions. The expression patterns of selected miRNAs were validated using quantitative reverse-transcription real-time polymerase chain reaction. Hierarchical clustering demonstrated microRNA expression profile in IPMC was significantly different from PDA, suggesting that different pathways are involved in these cancer types. Conclusion This study demonstrates that miRNAs are involved in the development and progression of IPMN. We identified potential targets for diagnosis, prognostication, and treatment of IPMN. Intraductal papillary mucinous neoplasms (IPMN) represent a spectrum of tumors that range from low-grade (LG) dysplastic tumors to invasive cancer. Identification of IPMN at high risk for malignant transformation is important for the prevention and early treatment of pancreatic cancer. The roles of microRNA expression in the development of IPMN have not been extensively evaluated. Expression patterns of 846 human microRNAs (miRNAs) was analyzed using microRNA microarray in 55 tissues, including LG IPMN (n = 10), moderate-grade (MG) IPMN (n = 5), high-grade (HG) IPMN (n = 5), invasive cancer with IPMN (IPMC; n = 10), pancreatic ductal adenocarcinoma without IPMN (PDA; n = 5), LG IPMN extracted from specimens that contain IPMC (LG_Ca; n = 10), and normal pancreatic tissues (n = 10). Fourteen miRNAs were differentially expressed in all IPMN tissues compared with normal pancreatic tissue. Expression level of 3 miRNAs was proportional to dysplasia level. Hierarchical clustering demonstrated grouping of 2 IPMN subgroups: LG and MG IPMN verses HG IPMN and IPMC. Expression of 15 miRNAs was significantly different between these groups. LG_Ca tissues clustered with the HG IPMC group, and 12 miRNAs were differentially expressed in LG_Ca, HG lesions, and IPMC compared with LG lesions. The expression patterns of selected miRNAs were validated using quantitative reverse-transcription real-time polymerase chain reaction. Hierarchical clustering demonstrated microRNA expression profile in IPMC was significantly different from PDA, suggesting that different pathways are involved in these cancer types. This study demonstrates that miRNAs are involved in the development and progression of IPMN. We identified potential targets for diagnosis, prognostication, and treatment of IPMN." @default.
- W2122724471 created "2016-06-24" @default.
- W2122724471 creator A5001549786 @default.
- W2122724471 creator A5008721490 @default.
- W2122724471 creator A5013728415 @default.
- W2122724471 creator A5015976718 @default.
- W2122724471 creator A5024869333 @default.
- W2122724471 creator A5037187848 @default.
- W2122724471 creator A5037650844 @default.
- W2122724471 creator A5045115112 @default.
- W2122724471 creator A5071994598 @default.
- W2122724471 creator A5085260720 @default.
- W2122724471 date "2013-05-01" @default.
- W2122724471 modified "2023-10-18" @default.
- W2122724471 title "MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas" @default.
- W2122724471 cites W1648301895 @default.
- W2122724471 cites W1975412433 @default.
- W2122724471 cites W1980409815 @default.
- W2122724471 cites W2000093333 @default.
- W2122724471 cites W2009365842 @default.
- W2122724471 cites W2020080445 @default.
- W2122724471 cites W2020830322 @default.
- W2122724471 cites W2044110303 @default.
- W2122724471 cites W2047213909 @default.
- W2122724471 cites W2051227958 @default.
- W2122724471 cites W2052783034 @default.
- W2122724471 cites W2052862446 @default.
- W2122724471 cites W2068516781 @default.
- W2122724471 cites W2069104846 @default.
- W2122724471 cites W2073400663 @default.
- W2122724471 cites W2074979262 @default.
- W2122724471 cites W2075329854 @default.
- W2122724471 cites W2079251691 @default.
- W2122724471 cites W2095138156 @default.
- W2122724471 cites W2098653030 @default.
- W2122724471 cites W2101995865 @default.
- W2122724471 cites W2112417639 @default.
- W2122724471 cites W2124603636 @default.
- W2122724471 cites W2126140528 @default.
- W2122724471 cites W2131753552 @default.
- W2122724471 cites W2133124222 @default.
- W2122724471 cites W2135810600 @default.
- W2122724471 cites W2135836598 @default.
- W2122724471 cites W2137456063 @default.
- W2122724471 cites W2142801414 @default.
- W2122724471 cites W2152036735 @default.
- W2122724471 cites W2155862681 @default.
- W2122724471 cites W2157615672 @default.
- W2122724471 cites W2170989872 @default.
- W2122724471 doi "https://doi.org/10.1016/j.surg.2012.11.016" @default.
- W2122724471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23305591" @default.
- W2122724471 hasPublicationYear "2013" @default.
- W2122724471 type Work @default.
- W2122724471 sameAs 2122724471 @default.
- W2122724471 citedByCount "49" @default.
- W2122724471 countsByYear W21227244712013 @default.
- W2122724471 countsByYear W21227244712014 @default.
- W2122724471 countsByYear W21227244712015 @default.
- W2122724471 countsByYear W21227244712016 @default.
- W2122724471 countsByYear W21227244712017 @default.
- W2122724471 countsByYear W21227244712018 @default.
- W2122724471 countsByYear W21227244712019 @default.
- W2122724471 countsByYear W21227244712020 @default.
- W2122724471 countsByYear W21227244712021 @default.
- W2122724471 countsByYear W21227244712022 @default.
- W2122724471 countsByYear W21227244712023 @default.
- W2122724471 crossrefType "journal-article" @default.
- W2122724471 hasAuthorship W2122724471A5001549786 @default.
- W2122724471 hasAuthorship W2122724471A5008721490 @default.
- W2122724471 hasAuthorship W2122724471A5013728415 @default.
- W2122724471 hasAuthorship W2122724471A5015976718 @default.
- W2122724471 hasAuthorship W2122724471A5024869333 @default.
- W2122724471 hasAuthorship W2122724471A5037187848 @default.
- W2122724471 hasAuthorship W2122724471A5037650844 @default.
- W2122724471 hasAuthorship W2122724471A5045115112 @default.
- W2122724471 hasAuthorship W2122724471A5071994598 @default.
- W2122724471 hasAuthorship W2122724471A5085260720 @default.
- W2122724471 hasConcept C104317684 @default.
- W2122724471 hasConcept C121608353 @default.
- W2122724471 hasConcept C126322002 @default.
- W2122724471 hasConcept C142724271 @default.
- W2122724471 hasConcept C145059251 @default.
- W2122724471 hasConcept C2775894508 @default.
- W2122724471 hasConcept C2776469228 @default.
- W2122724471 hasConcept C2778764654 @default.
- W2122724471 hasConcept C2780210213 @default.
- W2122724471 hasConcept C2781182431 @default.
- W2122724471 hasConcept C2992026798 @default.
- W2122724471 hasConcept C502942594 @default.
- W2122724471 hasConcept C55493867 @default.
- W2122724471 hasConcept C71924100 @default.
- W2122724471 hasConcept C86803240 @default.
- W2122724471 hasConcept C90924648 @default.
- W2122724471 hasConceptScore W2122724471C104317684 @default.
- W2122724471 hasConceptScore W2122724471C121608353 @default.
- W2122724471 hasConceptScore W2122724471C126322002 @default.
- W2122724471 hasConceptScore W2122724471C142724271 @default.
- W2122724471 hasConceptScore W2122724471C145059251 @default.